These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37953025)

  • 1. Targeted Therapies for Microvascular Disease.
    Bland A; Chuah E; Meere W; Ford TJ
    Heart Fail Clin; 2024 Jan; 20(1):91-99. PubMed ID: 37953025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Therapies for Microvascular Disease.
    Bland A; Chuah E; Meere W; Ford TJ
    Cardiol Clin; 2024 Feb; 42(1):137-145. PubMed ID: 37949535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Therapies for Microvascular Disease.
    Bland A; Chuah E; Meere W; Ford TJ
    Interv Cardiol Clin; 2023 Jan; 12(1):131-139. PubMed ID: 36372457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berries and Their Polyphenols as a Potential Therapy for Coronary Microvascular Dysfunction: A Mini-Review.
    Najjar RS; Schwartz AM; Wong BJ; Mehta PK; Feresin RG
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know.
    Marano P; Wei J; Merz CNB
    Curr Atheroscler Rep; 2023 Aug; 25(8):435-446. PubMed ID: 37338666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction.
    Lee SH; Shin D; Lee JM; van de Hoef TP; Hong D; Choi KH; Hwang D; Boerhout CKM; de Waard GA; Jung JH; Mejia-Renteria H; Hoshino M; Echavarria-Pinto M; Meuwissen M; Matsuo H; Madera-Cambero M; Eftekhari A; Effat MA; Murai T; Marques K; Doh JH; Christiansen EH; Banerjee R; Kim HK; Nam CW; Niccoli G; Nakayama M; Tanaka N; Shin ES; Chamuleau SAJ; van Royen N; Knaapen P; Koo BK; Kakuta T; Escaned J; Piek JJ;
    J Am Heart Assoc; 2022 May; 11(9):e025171. PubMed ID: 35475358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of coronary microvascular dysfunction.
    Bairey Merz CN; Pepine CJ; Shimokawa H; Berry C
    Cardiovasc Res; 2020 Mar; 116(4):856-870. PubMed ID: 32087007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of coronary microvascular dysfunction.
    Crea F; Montone RA
    Vascul Pharmacol; 2023 Dec; 153():107239. PubMed ID: 37898380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of hemodynamic indices of conjunctival microvascular function in patients with coronary microvascular dysfunction.
    Mailey JA; Moore JS; Brennan PF; Jing M; Awuah A; McLaughlin JAD; Nesbit MA; Moore TCB; Spence MS
    Microvasc Res; 2023 May; 147():104480. PubMed ID: 36690270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary microvascular dysfunction: Considerations for diagnosis and treatment.
    Tjoe B; Barsky L; Wei J; Samuels B; Azarbal B; Merz CNB; Shufelt C
    Cleve Clin J Med; 2021 Oct; 88(10):561-571. PubMed ID: 34598921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemia but no obstructive coronary artery disease: more than meets the eye.
    Patel N; Greene N; Guynn N; Sharma A; Toleva O; Mehta PK
    Climacteric; 2024 Feb; 27(1):22-31. PubMed ID: 38224068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of Coronary Microvascular Dysfunction.
    Crea F; Montone RA; Rinaldi R
    Circ J; 2022 Aug; 86(9):1319-1328. PubMed ID: 34759123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary Microvascular Dysfunction: A Practical Approach to Diagnosis and Management.
    Bechsgaard DF; Prescott E
    Curr Atheroscler Rep; 2021 Jul; 23(9):54. PubMed ID: 34268637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nonobstructive coronary stenosis on coronary microvascular dysfunction and long-term outcomes in patients with INOCA.
    Mohammed AA; Zhang H; Abdu FA; Liu L; Singh S; Lv X; Shi T; Mareai RM; Mohammed AQ; Yin G; Zhang W; Xu Y; Che W
    Clin Cardiol; 2023 Feb; 46(2):204-213. PubMed ID: 36567512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perturbations in myocardial perfusion and oxygen balance in swine with multiple risk factors: a novel model of ischemia and no obstructive coronary artery disease.
    van de Wouw J; Sorop O; van Drie RWA; van Duin RWB; Nguyen ITN; Joles JA; Verhaar MC; Merkus D; Duncker DJ
    Basic Res Cardiol; 2020 Feb; 115(2):21. PubMed ID: 32100119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.
    Mehta PK; Quesada O; Al-Badri A; Fleg JL; Volgman AS; Pepine CJ; Merz CNB; Shaw LJ
    Int J Cardiol; 2022 Feb; 348():1-8. PubMed ID: 34902504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary Microvascular Dysfunction and Hypertension: A Bond More Important than We Think.
    Zdravkovic M; Popadic V; Klasnja S; Klasnja A; Ivankovic T; Lasica R; Lovic D; Gostiljac D; Vasiljevic Z
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Targeted Therapies for Coronary Microvascular Dysfunction as Assessed by the Index of Microcirculatory Resistance.
    Xu J; Lo S; Juergens CP; Leung DY
    J Cardiovasc Transl Res; 2021 Apr; 14(2):327-337. PubMed ID: 32710373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary Microvascular Dysfunction　- Epidemiology, Pathogenesis, Prognosis, Diagnosis, Risk Factors and Therapy.
    Chen C; Wei J; AlBadri A; Zarrini P; Bairey Merz CN
    Circ J; 2016 Dec; 81(1):3-11. PubMed ID: 27904032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary microvascular dysfunction in Takotsubo syndrome and associations with left ventricular function.
    Ekenbäck C; Nickander J; Jokhaji F; Tornvall P; Engblom H; Spaak J; Persson J
    ESC Heart Fail; 2023 Aug; 10(4):2395-2405. PubMed ID: 37218383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.